Related references
Note: Only part of the references are listed.A unified mechanism for proteolysis and autocatalytic activation in the 20S proteasome
Eva M. Huber et al.
NATURE COMMUNICATIONS (2016)
ProteoPlex: stability optimization of macromolecular complexes by sparse-matrix screening of chemical space
Ashwin Chari et al.
NATURE METHODS (2015)
Bortezomib-Resistant Mutant Proteasomes: Structural and Biochemical Evaluation with Carfilzomib and ONX 0914
Eva M. Huber et al.
STRUCTURE (2015)
Crystal Structure of the Human 20S Proteasome in Complex with Carfilzomib
Wayne Harshbarger et al.
STRUCTURE (2015)
Cryo-EM reveals the conformation of a substrate analogue in the human 20S proteasome core
Paula C. A. da Fonseca et al.
NATURE COMMUNICATIONS (2015)
The 26S proteasome is a multifaceted target for anti-cancer therapies
Tatyana A. Grigoreva et al.
ONCOTARGET (2015)
Quantum Chemical Studies of Mechanisms for Metalloenzymes
Margareta R. A. Blomberg et al.
CHEMICAL REVIEWS (2014)
Structural Biology of the Proteasome
Erik Kish-Trier et al.
ANNUAL REVIEW OF BIOPHYSICS, VOL 42 (2013)
JLigand: a graphical tool for the CCP4 template-restraint library
Andrey A. Lebedev et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2012)
Immuno- and Constitutive Proteasome Crystal Structures Reveal Differences in Substrate and Inhibitor Specificity
Eva M. Huber et al.
CELL (2012)
The ORCA program system
Frank Neese
WILEY INTERDISCIPLINARY REVIEWS-COMPUTATIONAL MOLECULAR SCIENCE (2012)
Elucidation of the alpha-Keto-Aldehyde Binding Mechanism: A Lead Structure Motif for Proteasome Inhibition
Melissa Ann Graewert et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2011)
Effect of the Damping Function in Dispersion Corrected Density Functional Theory
Stefan Grimme et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2011)
XDS
Wolfgang Kabsch
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
Features and development of Coot
P. Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
Recognition and Processing of Ubiquitin-Protein Conjugates by the Proteasome
Daniel Finley
ANNUAL REVIEW OF BIOCHEMISTRY (2009)
Antitumor activity of PR-171, a novel irreversible inhibitor of the proteasome
Susan D. Demo et al.
CANCER RESEARCH (2007)
United States Food and Drug Administration approval summary: Bortezomib for the treatment of progressive multiple myeloma after one prior therapy
Robert C. Kane et al.
CLINICAL CANCER RESEARCH (2006)
A post-Hartree-Fock model of intermolecular interactions: Inclusion of higher-order corrections
ER Johnson et al.
JOURNAL OF CHEMICAL PHYSICS (2006)
Balanced basis sets of split valence, triple zeta valence and quadruple zeta valence quality for H to Rn: Design and assessment of accuracy
F Weigend et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2005)
Crystal structure of epoxomicin:20S proteasome reveals a molecular basis for selectivity of α′,β′-epoxyketone proteasome inhibitors
M Groll et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2000)
Share Paper
